Biopolym. Cell. 1997; 13(4):308-313.
http://dx.doi.org/10.7124/bc.000490
Genome and Its Regulation
Transforming growth factor a production, EGF receptor level and expression of transformed phenotype in HEp-2 human carcinoma cells transfected with HIV-1 tat gene
1Phylchenkov A. A., 2Yakimovich I. A., 2Korchinsky A. G., 1Kudryavels Yu. I., 2Stoika R. S.
  1. R. E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine
    45, Vasilkivska Str., Kyiv, Ukraine, 01022
  2. Division of Cell Regulatory Systems of O.V. Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine
    14/16, Drahomanov Str., Lviv, Ukraine, 79005

Abstract

Several clones of HEp-2 human carcinoma cells transfected with HIV-1 lot regulatory gene were studied for the presence of transforming growth factor a (TGF-α) activity in the serum-free culture medium conditioned by these cells, the level of epidermal growth factor (EGF)lTGF-α receptors and the expression of transformed phenotype. Clone A5st was shown to secrete growth stimulating factors whose activity was inhibited by the monoclonal antibody against TGF-α. The cells of alt studied clones possessed the same level of EGF/ TGF-α receptors measured by two different, methods – indirect flow cytometry and radioreceptor analysis. The expression of transformed phenotype (estimated on the basis of intensity of colonyforming by the cells cultured in the medium supplemented with 0.33 % agar) did not change under the effect of EGF in A5st clone producing TGF-α immunoreactive factors. But this expression was induced in the other studied clones of HEp-2 cells. Thus, the expression of HIV-1 tat regulatory gene can induce cellular production of TGF-α which participates in the cell transformation and in this way increases the risk of development of oncological diseases in AIDS patients.
Full text: (PDF, in Ukrainian)

References

[1] Vogel J, Hinrichs SH, Napolitano LA, Ngo L, Jay G. Liver cancer in transgenic mice carrying the human immunodeficiency virus tat gene. Cancer Res. 1991;51(24):6686-90.
[2] Roth WK. TGF beta and FGF-like growth factors involved in the pathogenesis of AIDS-associated Kaposi's sarcoma. Res Virol. 1993;144(1):105-9.
[3] Rizzino A, Ruff E, Rizzino H. Induction and modulation of anchorage-independent growth by platelet-derived growth factor, fibroblast growth factor, and transforming growth factor-beta. Cancer Res. 1986;46(6):2816-20.
[4] Yakimovich IA, Stoika RS, Kusen SI. Effect of basic fibroblast growth factor and its combinations with transforming type b growth factor and insulin on the anchorage-independent proliferation of the CHO-719 line cells. Eksp Oncol. 1993; 15(4): 59-61.
[5] Werner S, Viehweger P, Hofschneider PH, Roth WK. Low mitogenic response to EGF and TGF-alpha: a characteristic feature of cultured Kaposi's sarcoma derived cells. Oncogene. 1991;6(1):59-64.
[6] Kim CM, Vogel J, Jay G, Rhim JS. The HIV tat gene transforms human keratinocytes. Oncogene. 1992;7(8):1525-9.
[7] Filchenkov AA, Stoika RS, Bykorez AI. Transforming growth factors. Kiev: Naukova Dumka. 1993. 292 p.
[8] Filchenkov AA, Ivashchenko YuD, Kulik GA. Purification of epidermal growth factor byhydrophobic chromatography. Exp Oncol. 1991; 13(5):71-4.
[9] Greenwood FC, Hunter WM, Glover JS. The preparation of I-131-labelled human growth hormone of high specific radioactivity. Biochem J. 1963;89:114-23.
[10] Stoika RS, Sushelnitsky SI, Kusen' SI. The influence of transforming growth factor ?, epidermal growth factor and insulin on DNA biosynthesis in mouse fibroblasts of swiss-3T3 line grown in monolayer cultures with low and high cell density. Biopolym Cell. 1992; 8(4):39-43.
[11] Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: a laboratory manual. New York: Cold Spring Harbor Lab, 1982; 545 p.
[12] Phylchenkov AA, Slukvin II, Pogrebnoy PV, Kudryavets YuI, Didkovskaya LP, Kulik GA, Chernishov VP, Bykorez AI. Application of flow cytometry with anti-EGF-receptor antibody and 125I-EGF binding assay for detection EGF-receptors in certain human tumor cells lines. Eksp Oncol. 1992. 14(1): 45-9.
[13] Phylchenkov AA, Slukvin II, Kudryavets YuI, Didkovskaya LP, Kulik GA, Chernishov VP, Bykorez AI. Expression and functional activity of transferrine receptor in human tumour cells of different histogenesis. Eksp Oncol. 1992; 14(6):22-7.
[14] Sto?ka RS, Sushel'nitski? SI, Kusen' SI. The effect of transforming growth factor beta on the intensity of cellular DNA synthesis in relation to the type and conditions of cultivation. Tsitologiia. 1990;32(2):132-9.
[15] Derynck R. Transforming growth factor alpha. Cell. 1988;54(5):593-5. Review.
[16] Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS, Berger WH. Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res. 1987;47(3):707-12.
[17] * Stoika R. S., Yakimovych J. A., Antonenko S. V. et at. Transforming activity of growth factors in blood serum of AIDS and Kaposhi sarcoma patients. Exp. Oncol. 1995. 17, N 1: 3-9.